← SynDRA
BX 471 FREE BASE
SynDRA canonical compound SYN0007567 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CCR1 |
|---|
| Mechanism of action | CC chemokine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- CC chemokine receptor antagonist
- CCR1 ANTAGONIST
Cross-references
Synonyms
- BX-741
- ZK-811752
- BX-471 free base
- RefChem:122433
- DTXCID8098655
- C21H24ClFN4O3
- MFCD09859709
- BX-471free base
- UNII-76K17ZG4ZN
- GTPL767
- orb1305576
- SCHEMBL4586646
- SCHEMBL29416828
- EX-A519
- XQYASZNUFDVMFH-CQSZACIVSA-N
- GLXC-05630
- BDBM50174703
- BDBM50208999
- AKOS024457640
- Zk-811752(bx-471)
- CS-3283
- NCGC00370909-03
- NCGC00370909-05
- NCGC00370909-07
- AC-31379
- BS-16630
- FC101798
- HY-12080
- SY249762
- BX-471ZK 811752?
- B6060
- BRD-K91825936-001-01-2
- BX471; BX 471; BX-471; ZK811752; ZK 811752; ZK-811752
- bx-471
- bx-471 free base
- (R)-1-(5-Chloro-2-(2-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)phenyl)urea hydrochloride
- BS-16429
- BX471hydrochloride
- BAY-86-5047
Look up BX 471 FREE BASE in the interactive SynDRA portal →